01 July
2021
4basebio UK
Societas
(the "Company")
Director’s Dealing
4basebio UK Societas (AIM: 4BB), the specialist life sciences
group focused on exploiting its intellectual property in the field
of gene therapies and DNA vaccines, announces that, on 1 July 2021, Heikki
Lanckriet, chief executive officer, acquired 3,450 ordinary
shares at an average price of 467
pence per share on behalf of persons closely associated with
him.
As a result of the acquisition of ordinary shares, Heikki
Lanckriet’s beneficial holding, including shares held by persons
closely associated with him, comprises 1,243,453 ordinary shares
representing 10.10 per cent. of the Company’s issued share
capital.
This announcement contains inside information for the purposes
of Article 7 of EU Regulation 596/2014.
For further enquiries, please
contact:
| 4basebio UK
Societas
|
+44 (0)12 2396
7943 |
| Heikki Lanckriet,
CEO |
|
|
|
| Cairn Financial
Advisers LLP (Nominated Adviser) |
+44 (0)20 7213
0880 |
| Jo Turner / Sandy
Jamieson |
|
|
|
| finnCap Ltd
(Broker) |
+44 (0)20 7220
0500 |
| Geoff Nash/Richard
Chambers/Charlotte Sutcliffe |
|
|
|
| Walbrook PR |
+44 (0)20 7933
8780 |
| Anna Dunphy / Paul McManus |
Mob: +44
(0)7876 441 001 / +44 (0)7980 541 893 |
|
|
|
|
|
Notification and public disclosure of
transactions by persons discharging managerial responsibilities and
persons closely associated with them
Notification of a Transaction pursuant to Article 19(1) of
Regulation (EU) No. 596/2014
1. Details of the
person discharging managerial responsibilities/person closely
associated
a. Name
Heikki Lanckriet
2. Reason for
notification
a. Position/Status
Chief Executive Officer
b. Initial
notification/ Amendment Initial
3. Details of the
issuer, emission allowance market participant, auction platform,
auctioneer or auction monitor
a. Name
4basebio UK Societas
b. LEI
2138005D5SAG8FIR6G91
4. Details of the
transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and
(iv) each place where transactions have been conducted
a. Description of the
financial instrument, type Ordinary Shares of instrument
Identification Code
ISIN: GB00BLD8ZL39
b. Nature of the
transaction
Acquisition of ordinary shares
c. Price(s) and
volume(s) Volume(s)
Price
(p)
a.
1,500
467p
b.
650
467p
c.
650
467p
d.
650
467p
d. Aggregated
information
- Aggregated Volume
3,450
-
Price
467 pence per share
e. Date of the
transaction
1/7/2021
f. Place of the
transaction London Stock Exchange, AIM